320 related articles for article (PubMed ID: 32880303)
21. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
Sharun K; Tiwari R; Iqbal Yatoo M; Patel SK; Natesan S; Dhama J; Malik YS; Harapan H; Singh RK; Dhama K
Expert Opin Biol Ther; 2020 Sep; 20(9):1033-1046. PubMed ID: 32744917
[TBL] [Abstract][Full Text] [Related]
22. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
Majbour N; El-Agnaf O
Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
[TBL] [Abstract][Full Text] [Related]
23. Perspectives of Immune Therapy in Coronavirus Disease 2019.
Gasparyan AY; Misra DP; Yessirkepov M; Zimba O
J Korean Med Sci; 2020 May; 35(18):e176. PubMed ID: 32383371
[TBL] [Abstract][Full Text] [Related]
24. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.
Mansourabadi AH; Sadeghalvad M; Mohammadi-Motlagh HR; Rezaei N
Life Sci; 2020 Oct; 258():118185. PubMed ID: 32750438
[TBL] [Abstract][Full Text] [Related]
25. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
[No Abstract] [Full Text] [Related]
26. Why should we use convalescent plasma for COVID-19?
Franchini M
Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
[No Abstract] [Full Text] [Related]
27. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
28. Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic.
Sullivan HC; Roback JD
Transfus Med Rev; 2020 Jul; 34(3):145-150. PubMed ID: 32359788
[TBL] [Abstract][Full Text] [Related]
29. Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A
J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844
[TBL] [Abstract][Full Text] [Related]
30. Management of COVID-19 Virus Infection by Convalescent Plasma.
Cheraghali AM; Abolghasemi H; Eshghi P
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
[TBL] [Abstract][Full Text] [Related]
31. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
Tamburello A; Marando M
Swiss Med Wkly; 2020 Apr; 150():w20264. PubMed ID: 32343358
[No Abstract] [Full Text] [Related]
33. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19.
Rubin R
JAMA; 2020 Jun; 323(21):2114-2117. PubMed ID: 32352484
[No Abstract] [Full Text] [Related]
34. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
Lindholm PF; Ramsey G; Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
[TBL] [Abstract][Full Text] [Related]
35. [Use of convalescent plasma for COVID-19 treatment. History and evidence].
McAllister F; Mantegazza A; Garzón F; Rotbaum V; Remondino G; Vazquez Larsson M; Geffner J; Rabinovich GA; Bover L
Medicina (B Aires); 2020; 80 Suppl 3():82-86. PubMed ID: 32658853
[No Abstract] [Full Text] [Related]
36. COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains.
Gniadek TJ; Donnersberger D
Transfusion; 2020 Jul; 60(7):1643-1644. PubMed ID: 32428966
[No Abstract] [Full Text] [Related]
37. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
[TBL] [Abstract][Full Text] [Related]
38. Convalescent plasma for COVID-19: Promising, not proven.
Mucha SR; Quraishy N
Cleve Clin J Med; 2020 Nov; 87(11):664-670. PubMed ID: 32759176
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.
Devasenapathy N; Ye Z; Loeb M; Fang F; Najafabadi BT; Xiao Y; Couban R; Bégin P; Guyatt G
CMAJ; 2020 Jul; 192(27):E745-E755. PubMed ID: 32444482
[TBL] [Abstract][Full Text] [Related]
40. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
Prajapati S
Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
